Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia

{ 'indexed': {'date-parts': [[2024, 5, 13]], 'date-time': '2024-05-13T12:37:47Z', 'timestamp': 1715603867136}, 'reference-count': 30, 'publisher': 'Springer Science and Business Media LLC', 'issue': '3', 'license': [ { 'start': { 'date-parts': [[2021, 5, 11]], 'date-time': '2021-05-11T00:00:00Z', 'timestamp': 1620691200000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by-nc/4.0'}, { 'start': { 'date-parts': [[2021, 5, 11]], 'date-time': '2021-05-11T00:00:00Z', 'timestamp': 1620691200000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by-nc/4.0'}], 'funder': [{'DOI': '10.13039/100011842', 'name': 'Sharp HealthCare', 'doi-asserted-by': 'publisher'}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2021, 9]]}, 'DOI': '10.1007/s40121-021-00453-3', 'type': 'journal-article', 'created': {'date-parts': [[2021, 5, 11]], 'date-time': '2021-05-11T22:02:50Z', 'timestamp': 1620770570000}, 'page': '1323-1330', 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 26, 'title': 'Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan ' 'to Hospitalized COVID-19 Patients with Mild Hypoxemia', 'prefix': '10.1007', 'volume': '10', 'clinical-trial-number': [ { 'clinical-trial-number': 'nct04340557', 'registry': '10.18810/clinical-trials-gov'}], 'author': [ {'given': 'Matthew', 'family': 'Geriak', 'sequence': 'first', 'affiliation': []}, {'given': 'Fadi', 'family': 'Haddad', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ravina', 'family': 'Kullar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kristina L.', 'family': 'Greenwood', 'sequence': 'additional', 'affiliation': []}, {'given': 'MacKenzie', 'family': 'Habib', 'sequence': 'additional', 'affiliation': []}, {'given': 'Cole', 'family': 'Habib', 'sequence': 'additional', 'affiliation': []}, {'given': 'David', 'family': 'Willms', 'sequence': 'additional', 'affiliation': []}, {'given': 'George', 'family': 'Sakoulas', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2021, 5, 11]]}, 'reference': [ { 'key': '453_CR1', 'doi-asserted-by': 'publisher', 'first-page': '5017', 'DOI': '10.1016/S0140-6736(20)30211-7', 'volume': '395', 'author': 'N Chen', 'year': '2020', 'unstructured': 'Chen N, Zhou M, Dong X, et al. Epidemiological and clinical ' 'characteristics of 99 cases of 2019 novel coronavirus pneumonia in ' 'Wuhan, China: a descriptive study. Lancet. 2020;395:5017–513. ' 'https://doi.org/10.1016/S0140-6736(20)30211-7.', 'journal-title': 'Lancet'}, { 'key': '453_CR2', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.healun.2020.03.012', 'author': 'HK Siddiqu', 'year': '2020', 'unstructured': 'Siddiqu HK, Mehra MR. COVID-19 illness in native and immunosuppressed ' 'states: a clinical-therapeutic staging proposal. J Heart Lung ' 'Transplant. 2020. https://doi.org/10.1016/j.healun.2020.03.012.', 'journal-title': 'J Heart Lung Transplant'}, { 'key': '453_CR3', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/cid/ciaa248', 'author': 'C Qin', 'year': '2020', 'unstructured': 'Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients ' 'with COVID-19 in Wuhan, China. Clin Infect Dis. 2020. ' 'https://doi.org/10.1093/cid/ciaa248.', 'journal-title': 'Clin Infect Dis'}, { 'key': '453_CR4', 'doi-asserted-by': 'publisher', 'first-page': '11727', 'DOI': '10.1073/pnas.2003138117', 'volume': '117', 'author': 'J Shang', 'year': '2020', 'unstructured': 'Shang J, Wan Y, et al. Cell entry mechanisms of SARS-CoV-2. PNAS. ' '2020;117:11727–34. https://doi.org/10.1073/pnas.2003138117.', 'journal-title': 'PNAS'}, { 'key': '453_CR5', 'doi-asserted-by': 'publisher', 'first-page': '1176', 'DOI': '10.1161/CIRCULATIONAHA.120.048488', 'volume': '142', 'author': 'L Nicolai', 'year': '2020', 'unstructured': 'Nicolai L, Leunig A, Brambs S, Kaiser R, Weinberger T, Weigand M, ' 'Muenchhoff M, Hellmuth JC, Ledderose S, Schulz H, Scherer C, Rudelius M, ' 'Zoller M, Hochter D, Keppler O, Teupser D, Zwibler B, von ' 'Bergwelt-Baildon M, Kaab S, Massberg S, Pekayyvaz K, Stark K. ' 'Immunothrombotic dysregulation in COVID-19 pneumonia is associated with ' 'respiratory failure and coagulopathy. Circulation. 2020;142:1176–89 ' '(e-pub).', 'journal-title': 'Circulation'}, { 'key': '453_CR6', 'doi-asserted-by': 'publisher', 'first-page': '7527953', 'DOI': '10.1155/2020/7527953', 'volume': '2020', 'author': 'S Cicco', 'year': '2020', 'unstructured': 'Cicco S, Cicco G, Racanelli V, Vacca A. Neutrophil extracellular traps ' '(NETs) and damage-associated molecular patterns (DAMPs): two potential ' 'targets for COVID-19 treatment. Mediat Inflamm. 2020;2020:7527953. ' 'https://doi.org/10.1155/2020/7527953.', 'journal-title': 'Mediat Inflamm'}, { 'issue': '3', 'key': '453_CR7', 'doi-asserted-by': 'publisher', 'first-page': '544', 'DOI': '10.1080/14397595.2019.1602292', 'volume': '30', 'author': 'R Uozumi', 'year': '2020', 'unstructured': 'Uozumi R, Iguchi R, Masuda S, Nishibata Y, Nakazawa D, Tomaru U, Ishizu ' 'A. Pharmaceutical immunoglobulins reduce neutrophil extracellular trap ' 'formation and ameliorate the development of MPO-ANCA-associated ' 'vasculitis. Mod Rheumatol. 2020;30(3):544–50. ' 'https://doi.org/10.1080/14397595.2019.1602292.', 'journal-title': 'Mod Rheumatol'}, { 'key': '453_CR8', 'unstructured': 'https://www.clinicaltrials.gov/ct2/results?cond=Coronavirus&term=losartan&cntry=&state=&city=&dist=.'}, { 'key': '453_CR9', 'doi-asserted-by': 'publisher', 'first-page': '985', 'DOI': '10.1038/s41440-020-0488-z', 'volume': '43', 'author': 'MM Ciulla', 'year': '2020', 'unstructured': 'Ciulla MM. SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ' 'ACEIs/ARBs. Hypertens Res. 2020;43:985–6. ' 'https://doi.org/10.1038/s41440-020-0488-z.', 'journal-title': 'Hypertens Res'}, { 'issue': '5', 'key': '453_CR10', 'doi-asserted-by': 'publisher', 'first-page': '537', 'DOI': '10.1002/ddr.21656', 'volume': '81', 'author': 'D Gurwitz', 'year': '2020', 'unstructured': 'Gurwitz D. Angiotensin receptor blockers as tentative SARS-CoV-2 ' 'therapeutics. Drug Dev Res. 2020;81(5):537–40. ' 'https://doi.org/10.1002/ddr.21656 (Epub 2020 Mar 4).', 'journal-title': 'Drug Dev Res.'}, { 'issue': '11', 'key': '453_CR11', 'doi-asserted-by': 'publisher', 'first-page': 'e0280', 'DOI': '10.1097/CCE.0000000000000280.PMID:33225306;PMCID:PMC7671875', 'volume': '2', 'author': 'G Sakoulas', 'year': '2020', 'unstructured': 'Sakoulas G, Geriak M, Kullar R, Greenwood KL, Habib M, Vyas A, ' 'Ghafourian M, Dintyala VNK, Haddad F. Intravenous immunoglobulin plus ' 'methylprednisolone mitigate respiratory morbidity in coronavirus disease ' '2019. Crit Care Explor. 2020;2(11):e0280. ' 'https://doi.org/10.1097/CCE.0000000000000280.PMID:33225306;PMCID:PMC7671875.', 'journal-title': 'Crit Care Explor'}, { 'issue': '5', 'key': '453_CR12', 'doi-asserted-by': 'publisher', 'first-page': 'e02483', 'DOI': '10.1128/AAC.02483-18', 'volume': '63', 'author': 'M Geriak', 'year': '2019', 'unstructured': 'Geriak M, Haddad F, Rizvi K, Rose W, LaPlante K, Yu M, Vasina L, ' 'Ouellette K, Zervos M, Nizet V, Sakoulas G. Clinical data on daptomycin ' 'plus ceftaroline versus standard of care monotherapy in the treatment of ' 'methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob ' 'Agents Chemother. 2019;63(5):e02483-e2518. ' 'https://doi.org/10.1128/AAC.02483-18.', 'journal-title': 'Antimicrob Agents Chemother'}, { 'issue': '3', 'key': '453_CR13', 'doi-asserted-by': 'publisher', 'first-page': '195', 'DOI': '10.7326/M20-1515', 'volume': '173', 'author': 'K Mackey', 'year': '2020', 'unstructured': 'Mackey K, King VJ, Gurley S, Kiefer M, Liederbauer E, Vela K, Sonnen P, ' 'Kansagara D. Risks and impact of angiotensin-converting enzyme ' 'inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in ' 'adults: a living systematic review. Ann Intern Med. 2020;173(3):195–203. ' 'https://doi.org/10.7326/M20-1515 (Epub 2020 May 15).', 'journal-title': 'Ann Intern Med.'}, { 'key': '453_CR14', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2008975', 'author': 'HR Reynolds', 'year': '2020', 'unstructured': 'Reynolds HR, et al. Renin–angiotensin–aldosterone system inhibitors and ' 'risk of Covid-19. N Engl J Med. 2020. ' 'https://doi.org/10.1056/NEJMoa2008975 (e-pub).', 'journal-title': 'N Engl J Med'}, { 'key': '453_CR15', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2006923', 'author': 'G Mancia', 'year': '2020', 'unstructured': 'Mancia G, et al. Renin–angiotensin–aldosterone system blockers and the ' 'risk of Covid-19. N Engl J Med. 2020. ' 'https://doi.org/10.1056/NEJMoa2006923 (e-pub).', 'journal-title': 'N Engl J Med'}, { 'key': '453_CR16', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S0140-6736(20)31030-8', 'author': 'FJ de Abajo', 'year': '2020', 'unstructured': 'de Abajo FJ, et al. Use of renin–angiotensin–aldosterone system ' 'inhibitors and risk of COVID-19 requiring admission to hospital: a ' 'case-population study. Lancet. 2020. ' 'https://doi.org/10.1016/S0140-6736(20)31030-8 (e-pub).', 'journal-title': 'Lancet'}, { 'key': '453_CR17', 'doi-asserted-by': 'publisher', 'DOI': '10.1001/jamacardio.2020.1624', 'author': 'J Li', 'year': '2020', 'unstructured': 'Li J, et al. Association of renin-angiotensin system inhibitors with ' 'severity or risk of death in patients with hypertension hospitalized for ' 'coronavirus disease 2019 (COVID-19) infection in Wuhan, China. JAMA ' 'Cardiol. 2020. https://doi.org/10.1001/jamacardio.2020.1624 (e-pub).', 'journal-title': 'JAMA Cardiol'}, { 'key': '453_CR18', 'doi-asserted-by': 'publisher', 'DOI': '10.1161/CIRCRESAHA.120.317134', 'author': 'P Zhang', 'year': '2020', 'unstructured': 'Zhang P, et al. Association of inpatient use of angiotensin converting ' 'enzyme inhibitors and angiotensin II receptor blockers with mortality ' 'among patients with hypertension hospitalized with COVID-19. Circ Res. ' '2020. https://doi.org/10.1161/CIRCRESAHA.120.317134 (e-pub).', 'journal-title': 'Circ Res'}, { 'key': '453_CR19', 'doi-asserted-by': 'publisher', 'DOI': '10.1101/2020.04.07.20056788', 'author': 'DM Bean', 'year': '2020', 'unstructured': 'Bean DM, et al. Treatment with ACE-inhibitors is associated with less ' 'severe disease with SARS-Covid-19 infection in a multi-site UK acute ' 'hospital trust. MedRxiv. 2020. ' 'https://doi.org/10.1101/2020.04.07.20056788 (Preprint).', 'journal-title': 'MedRxiv'}, { 'issue': '8', 'key': '453_CR20', 'doi-asserted-by': 'publisher', 'first-page': '1180', 'DOI': '10.1016/j.cjca.2020.05.033', 'volume': '36', 'author': 'RD Turgeon', 'year': '2020', 'unstructured': 'Turgeon RD, Zieroth S, Bewick D, Chow CM, Clarke B, Cowan S, Fordyce CB, ' 'Fournier A, Gin K, Gupta A, Hardiman S, Jackson S, Lau B, Leong-Poi H, ' 'Mansour S, Marelli A, Quraishi AR, Roifman I, Ruel M, Sapp J, Singh G, ' 'Small G, Virani S, Wood DA, Krahn A. Use of renin–angiotensin system ' 'blockers during the COVID-19 pandemic: early guidance and evolving ' 'evidence. Can J Cardiol. 2020;36(8):1180–2. ' 'https://doi.org/10.1016/j.cjca.2020.05.033 (Epub 2020 Jun 2).', 'journal-title': 'Can J Cardiol.'}, { 'issue': '25', 'key': '453_CR21', 'doi-asserted-by': 'publisher', 'first-page': '2042', 'DOI': '10.1161/CIRCULATIONAHA.120.047022', 'volume': '141', 'author': 'FH Messerli', 'year': '2020', 'unstructured': 'Messerli FH, Siontis GCM, Rexhaj E. COVID-19 and renin angiotensin ' 'blockers: current evidence and recommendations. Circulation. ' '2020;141(25):2042–4. https://doi.org/10.1161/CIRCULATIONAHA.120.047022 ' '(Epub 2020 Apr 13).', 'journal-title': 'Circulation'}, { 'key': '453_CR22', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/jmv.26695', 'author': 'G Zhang', 'year': '2020', 'unstructured': 'Zhang G, Wu Y, Xu R, Du X. Effects of renin–angiotensin–aldosterone ' 'system (RAAS) inhibitors on disease severity and mortality in patients ' 'with COVID-19: a meta-analysis. J Med Virol. 2020. ' 'https://doi.org/10.1002/jmv.26695 (Epub ahead of print).', 'journal-title': 'J Med Virol.'}, { 'key': '453_CR23', 'doi-asserted-by': 'publisher', 'DOI': '10.11622/smedj.2020159', 'author': 'XJ Cai', 'year': '2020', 'unstructured': 'Cai XJ, Tay JCK, Kui SL, Tin AS, Tan VH. Impact of ' 'angiotensin-converting enzyme inhibitors and angiotensin receptor ' 'blockers on in-hospital mortality in COVID-19 patients: a systematic ' 'review and meta-analysis. Singap Med J. 2020. ' 'https://doi.org/10.11622/smedj.2020159 (Epub ahead of print).', 'journal-title': 'Singap Med J.'}, { 'key': '453_CR24', 'doi-asserted-by': 'publisher', 'first-page': 'e4260', 'DOI': '10.1136/bmj.e4260', 'volume': '345', 'author': 'D Caldeira', 'year': '2012', 'unstructured': 'Caldeira D, Alarcão J, Vaz-Carneiro A, Costa J. Risk of pneumonia ' 'associated with use of angiotensin converting enzyme inhibitors and ' 'angiotensin receptor blockers: systematic review and meta-analysis. BMJ. ' '2012;345:e4260. https://doi.org/10.1136/bmj.e4260.', 'journal-title': 'BMJ'}, { 'key': '453_CR25', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2007764', 'author': 'JH Beigel', 'year': '2020', 'unstructured': 'Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of ' 'Covid-19—preliminary report [published online ahead of print, 2020 May ' '22]. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2007764.', 'journal-title': 'N Engl J Med.'}, { 'issue': '10236', 'key': '453_CR26', 'doi-asserted-by': 'publisher', 'first-page': '1569', 'DOI': '10.1016/S0140-6736(20)31022-9', 'volume': '395', 'author': 'Y Wang', 'year': '2020', 'unstructured': 'Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: ' 'a randomised, double-blind, placebo-controlled, multicentre trial ' '[published correction appears in Lancet. 2020 May 30;395(10238):1694]. ' 'Lancet. 2020;395(10236):1569–78. ' 'https://doi.org/10.1016/S0140-6736(20)31022-9.', 'journal-title': 'Lancet'}, { 'key': '453_CR27', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2015301', 'author': 'JD Goldman', 'year': '2020', 'unstructured': 'Goldman JD, Lye DCB, Hui DS, et al. Remdesivir for 5 or 10 days in ' 'patients with severe Covid-19 [published online ahead of print, 2020 May ' '27]. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2015301.', 'journal-title': 'N Engl J Med.'}, { 'key': '453_CR28', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2021436', 'author': 'P Horby', 'year': '2020', 'unstructured': 'RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in ' 'hospitalized patients with Covid-19—preliminary report [published online ' 'ahead of print, 2020 Jul 17]. N Engl J Med. 2020. ' 'https://doi.org/10.1056/NEJMoa2021436.', 'journal-title': 'N Engl J Med.'}, { 'issue': '371', 'key': '453_CR29', 'doi-asserted-by': 'publisher', 'first-page': 'm4362', 'DOI': '10.1136/bmj.m4362', 'volume': '11', 'author': 'E Mahase', 'year': '2020', 'unstructured': 'Mahase E. Covid-19: FDA authorises neutralising antibody bamlanivimab ' 'for non-admitted patients. BMJ. 2020;11(371):m4362. ' 'https://doi.org/10.1136/bmj.m4362.', 'journal-title': 'BMJ'}, { 'key': '453_CR30', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2023184', 'author': 'H Pan', 'year': '2020', 'unstructured': 'WHO Solidarity Trial Consortium, Pan H, Peto R, Henao-Restrepo AM, ' 'Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, Alejandria MM, Hernández ' 'García C, Kieny MP, Malekzadeh R, Murthy S, Reddy KS, Roses Periago M, ' 'Abi Hanna P, Ader F, Al-Bader AM, Alhasawi A, Allum E, Alotaibi A, ' 'Alvarez-Moreno CA, Appadoo S, Asiri A, Aukrust P, Barratt-Due A, Bellani ' 'S, Branca M, Cappel-Porter HBC, Cerrato N, Chow TS, Como N, Eustace J, ' 'García PJ, Godbole S, Gotuzzo E, Griskevicius L, Hamra R, Hassan M, ' 'Hassany M, Hutton D, Irmansyah I, Jancoriene L, Kirwan J, Kumar S, ' 'Lennon P, Lopardo G, Lydon P, Magrini N, Maguire T, Manevska S, Manuel ' 'O, McGinty S, Medina MT, Mesa Rubio ML, Miranda-Montoya MC, Nel J, Nunes ' 'EP, Perola M, Portolés A, Rasmin MR, Raza A, Rees H, Reges PPS, Rogers ' 'CA, Salami K, Salvadori MI, Sinani N, Sterne JAC, Stevanovikj M, ' 'Tacconelli E, Tikkinen KAO, Trelle S, Zaid H, Røttingen JA, Swaminathan ' 'S. Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial ' 'results. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2023184 (Epub ' 'ahead of print).', 'journal-title': 'N Engl J Med.'}], 'container-title': 'Infectious Diseases and Therapy', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1007/s40121-021-00453-3.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1007/s40121-021-00453-3/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1007/s40121-021-00453-3.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2021, 8, 10]], 'date-time': '2021-08-10T17:20:07Z', 'timestamp': 1628616007000}, 'score': 1, 'resource': {'primary': {'URL': 'https://link.springer.com/10.1007/s40121-021-00453-3'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 5, 11]]}, 'references-count': 30, 'journal-issue': {'issue': '3', 'published-print': {'date-parts': [[2021, 9]]}}, 'alternative-id': ['453'], 'URL': 'http://dx.doi.org/10.1007/s40121-021-00453-3', 'relation': {}, 'ISSN': ['2193-8229', '2193-6382'], 'subject': [], 'container-title-short': 'Infect Dis Ther', 'published': {'date-parts': [[2021, 5, 11]]}, 'assertion': [ { 'value': '28 April 2021', 'order': 1, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '11 May 2021', 'order': 2, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}]}